New York State Opioid Transaction Registry for 2021

Article 20-D of New York State Tax Law mandates this registry of all opioid sales within the state. The dataset details transactions from 2021, reported by manufacturers, wholesalers, and outsourcing facilities to the Department of Health. It was published by health.data.ny.gov and last updated in October 2024.

Use Cases

• Analyze the relationship between Total NY MMEs (Morphine Milligram Equivalents) and Drug Name or Strength Per Unit to assess the potency of opioids sold.
• Map the geographic distribution of opioid shipments using Registrant City, State, and Zip Code fields.
• Identify major market participants by aggregating Containers Count or Total Metric Quantity by Registrant Name.
• Examine transaction patterns over time using the Transaction Date column.
• Link specific drug products to regulatory identifiers by cross-referencing NDC Code with Drug Name.

Strengths

• Contains 17 specific columns detailing transaction, registrant, and drug information.
• Legally mandated reporting ensures a formal and structured data collection process.
• Data is recent, with a last update in October 2024.

Limitations

• The dataset is limited to a single year (2021) of transactions.
• The total number of rows (transactions) is unknown, preventing assessment of statistical significance.
• Geographic coverage is restricted to transactions within or into New York State.

Provenance

Source

health.data.ny.gov, from reports submitted under New York State Tax Law Article 20-D.

Collection Method

Mandatory self-reporting by registered opioid manufacturers, wholesalers, and outsourcing facilities.

Time Range

2021

Freshness

Annual report; last updated 2024-10-09.

Geography

Transactions into or within New York State, United States.